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Purpose. Colorectal anastomotic leakage (CAL) is one of the most severe complications after colorectal surgery. This meta-analysis
evaluates whether systemic or peritoneal inflammatory cytokines may contribute to early detection of CAL. Methods. Systematic
literature search was performed in the acknowledged medical databases according to the PRISMA guidelines to identify studies
evaluating systemic and peritoneal levels of TNF, IL-1𝛽, IL-6, and IL-10 for early detection of CAL. Means and standard deviations
of systemic and peritoneal cytokine levels were extracted, respectively, for patients with and without CAL. The meta-analysis of
the mean differences was carried out for each postoperative day using Review Manager. Results. Seven articles were included. The
meta-analysis was performed with 5 articles evaluating peritoneal cytokine levels. Peritoneal levels of IL-6 were significantly higher
in patients with CAL compared to patients without CAL on postoperative days 1, 2, and 3 (𝑃 < 0.05). Similar results were found
for peritoneal levels of TNF but on postoperative days 3, 4, and 5 (𝑃 < 0.05). The articles regarding systemic cytokine levels did not
report any significant difference accordingly.Conclusion. Increased postoperative levels of peritoneal IL-6 and TNF are significantly
associated with CAL and may contribute to its early detection.
1. Introduction
Despite the progress made in surgical techniques and periop-
erativemanagement, morbidity andmortality after colorectal
surgery remain problematic. One of the major causes is
colorectal anastomotic leakage (CAL), which contributes to
one-third of all postoperative deaths after colorectal surgery
[1]. CAL occurs in 3% to 20% [2–4] of patients after
colorectal surgery. It is a defect of the colorectal wall at
the anastomotic site leading to communication between the
intra- and extraluminal compartments [5]. Localized signs
such as abdominal pain and postoperative ileus, though being
considered as abdominal manifestations of CAL, are very
common after colorectal surgery and therefore provide lim-
ited diagnostic value [6]. Moreover, systemic manifestations
or parameters such as fever, increased leukocyte count, or
increased C-reactive protein (CRP) levels are actually also
frequently observed and therefore not sensitive in diagnosing
CAL [7].
With the current postoperative regimes, CAL is usually
confirmed by imaging studies such as endoscopy or CT scan.
The median day of diagnosis varies between postoperative
days 8 and 13 [8–10]. A recent review shows that more than
50% of CAL was at the highest severity when diagnosed,
which requires relaparotomy [11]. This indicates that many
early stages of CAL are not diagnosed until progressing to a
severe state. So the current regimes seem to be ineffective and
insufficient in many cases based on the high rates of invasive
reintervention [8, 9]. To this end, methods for early detection
of CAL require extensive further exploration.
Occurrence of CAL is a dynamic and progressive process.
Before systemic symptoms like fever, leukocytosis, and other
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septic symptoms become manifest, localized infection at
the site of the anastomosis first takes place [12], which
involves varying immune cells and cytokines [13]. Some
cytokines such as TNF, IL-1𝛽, and IL-6 are proinflammatory
cytokines that mediate inflammatory response, whereas IL-
10 is considered as an anti-inflammatory cytokine mod-
ulating the inflammation [14, 15]. Although the surgical
trauma also influences levels of these cytokines, abnormal
changes of the cytokines still indicate occurrence of the
infectious complications including anastomotic leakage. Pre-
vious studies have suggested that monitoring cytokine levels
in drain fluid or in blood samples may contribute to early
detection of CAL, while firm evidence is not available yet.
Therefore, this meta-analysis aims to evaluate the value of
peritoneal and systemic cytokine levels for early detection of
CAL.
2. Methods
The methods of this meta-analysis followed the PRISMA
(Preferred Reporting Items for Systematic Reviews andMeta-
Analyses) statement [16].
2.1. Literature Search. The literature search was performed
in Medline, Embase, Cochrane, Web of Science, and Google
Scholar libraries in August 2014 and updated in July 2015 by
two authors. No restrictions regarding publication date or
language were applied during the search strategy. The search
was restricted to human studies.
2.2. Study Selection. Titles and abstracts were screened for
relevance by two authors (Zhouqiao Wu and Adem Dereci)
independently. All full-text articles evaluating the predictive
value of TNF, IL-1𝛽, IL-6, and IL-10 in early detection of
CAL after colorectal surgery were selected. Articles without
a comparison between patients with and without CAL were
excluded; reviews, letters to editor, and congress abstracts
were excluded as well.
2.3. Quality Assessment. Two authors independently judged
the quality of included articles using theQUADAS-2 (Quality
Assessment in Diagnostic Accuracy Studies) method, which
evaluates the risk of bias and the applicability according
to four key domains including patient selection, index test,
reference standard, and flow and timing [17]. Level-of-
evidence was estimated according to Levels of Evidence 2011
from the Centre for Evidence Based Medicine [18].
2.4. Data Extraction. Two authors independently extracted
means and standard deviations (SD) of cytokine levels of
each postoperative day for patients with and without CAL,
respectively. Any discrepancies were resolved by reexamina-
tion of data until consensus was reached. The mean and SD
of cytokine levels per postoperative day were not provided in
the articles ofMatthiessen et al. [19] andYamamoto et al. [20].
Primary data of these articles were obtained from the authors
themselves.Theunit of levels of cytokineswas not reported by
Fouda et al. in their results [21] but was confirmed according
to the methods and the instruction of their ELISA kit [22].
All cytokine data were converted into the same unit ng/mL
in the meta-analysis.
2.5. Statistical Analysis. Quantitative statistical analysis for
binary outcomes was carried out using mean differences
with 95% confidence interval. The random-effects model
was applied to obtain the 95% confidence interval. Statistical
heterogeneity was calculated with the 𝐼2 statistic, which
represents the percentage of variation in study estimates
due to heterogeneity, and tested by the Cochran 𝑄 test
(modified 𝜒2 test). All statistical analyses were performed
using Review Manager version 5.3, the Nordic Cochrane
Centre, Copenhagen, Denmark.
3. Results
3.1. Results of Study Selection and Evaluation. Seven articles
met final inclusion criteria (Figure 1). All included studies
evaluated peritoneal or systemic cytokine levels after colorec-
tal surgery for the diagnosis of CAL (Table 1). All included
studies were found to be at high risk of bias while the
applicability was considered to be positive (Table 2).The high
risk of biaswas related to poor patient selection. Furthermore,
study designs of included studies led to a low level-of-
evidence.
Meta-analysis is a statistical method for pooling the
results of several studies reporting similar outcomes in order
to gain a better estimate of the effect size of an intervention. It
is appropriate to perform ameta-analysis when outcomes are
comparable and can be pooled meaningfully. Comparators
should be at least similar enough to be combined. All the
included studies reported cytokine levels on a similar scale
except for the studies of Ug˘ras¸ et al. [27] and Alonso et
al. [28]. The peritoneal cytokine levels reported by Ug˘ras¸ et
al. [27] are approximately 10 to 1000 times higher than the
data from the other studies, while the data from Alonso et
al. [28] are approximately 50 to 100 times lower than the
other inclusions. Despite both studies meeting final inclusion
criteria, they were not included in the meta-analysis for
peritoneal cytokines.
3.2. Definitions of CAL. The definitions of CAL were incon-
sistent between included studies (Table 3). The studies from
Fouda et al. [21] and Bertram et al. [23] based the definition
of CAL on clinical signs, mostly focusing on the aspect of
drain fluid; the study from Yamamoto et al. [20] included
additional imaging studies; the studies from Herwig et al.
[24] and Reisinger et al. [26] defined CAL by the necessity
of reintervention. The definitions of CAL in the studies from
Matthiessen et al. [19] and Ellebæk et al. [25] mainly focused
on a demonstrated defect of the intestinal wall.
3.3. ELISA (Enzyme-Linked Immunosorbent Assay). Al-
though most studies used ELISA to determine the cytokine
levels, different methods of measuring, handling, and storing
the samples were used in the included studies (Table 4).
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Records identified through database searching and from 
reference lists
Records screened Records excluded
Full-text articles assessed for eligibility
Studies included in qualitative synthesis
Studies included in quantitative synthesis 
(meta-analysis)
Literature update
July 2015
Studies not eligible for meta-analysis 
(n = 2)
(n = 890)
(n = 5)
(n = 7)
Data availability n = 1
No comparison n = 2
Index test n = 2
Inﬂuenced outcome n = 3
Other complications n = 7
No full text in English n = 10
Type of surgery n = 18
Full-text articles excluded, with the
(n = 50)
(n = 4441)
(n = 4491)
(n = 4491)
(n = 43):following reasons
Figure 1: PRISMA flow chart representing selection of articles for review.
3.4. Peritoneal Cytokines. In total we included 5 studies in the
meta-analysis for peritoneal levels of TNF, Il-6, and IL-1𝛽.
The meta-analysis regarding peritoneal levels of cytokines
included 228 patients who underwent colorectal surgery
between 1996 and 2010. The mean level of cytokines on
each postoperative day is reported in Figure 2 by calculating
the weighted mean of each included study. As is shown
in Figure 2 the peritoneal level of the cytokines varied
after surgery. TNF and IL-6 levels substantially increased in
patients with CAL while there was no or mild increase in
patients without CAL.
Peritoneal levels of TNF showed significant differences
between patients with and without CAL at POD3 (𝑃 = 0.04),
POD4 (𝑃 = 0.0002), and POD5 (𝑃 < 0.00001) (Figure 3).
The meta-analysis of POD3 included 4 studies while the
meta-analyses of POD4 and POD5 only included 2 studies.
Peritoneal levels of IL-6 were different between patients with
and without the CAL on POD1 (𝑃 = 0.05), POD2 (𝑃 = 0.03),
and POD3 (𝑃 = 0.002) (Figure 4). All analyses for IL-6 were
based on 4 or 5 independent studies on the first three days.
Nevertheless, peritoneal levels of IL-1𝛽 and IL-10 were only
reported in one or two studies. Although we still performed
themeta-analysis when possible, the results did not show sig-
nificant differences between patients with and without CAL
on each respective day (see Supplementary Material, Figure
S1, available online at http://dx.doi.org/10.1155/2016/3786418).
3.5. Systemic Cytokines. Two studies were included for eval-
uation of systemic cytokine levels after colorectal surgery
[25, 26]. Moreover, the primary data was not available in the
articles.Therefore, we did not perform ameta-analysis for the
systemic levels of cytokines. However, neither of the studies
showed any significant difference in the systemic cytokines
levels (TNF, IL-1𝛽, IL-6, and IL-10) between patients with and
without CAL.
4. Discussion
CAL remains a dangerous complication after colorectal
surgery. This meta-analysis summarizes previous literature
of early detection for CAL by measuring peritoneal and
systemic cytokine levels. Our data show that peritoneal levels
of proinflammatory cytokines (i.e., IL-6 and TNF) were
higher in patients with CAL during early postoperative days,
suggesting the diagnostic value of measuring the peritoneal
cytokine level after surgery.
Among the candidate cytokines, TNF and IL-6 showed
a statistically significant increase in CAL patients. These
inflammatory cytokines are mainly secreted by macrophages
and neutrophils, which infiltrate to the anastomotic area at
the first days after construction of anastomosis. Our previous
animal studies have demonstrated that a significantly larger
amount of iNOS+ (Inducible Nitric Oxide Synthase) produc-
ing cells (mainly macrophages subtype 1) infiltrates into the
anastomotic area in theCAL cases compared to thosewithout
CAL within the first postoperative days [29]. In accordance
with previous evidence, current data confirm the localized
mechanism during the early stage of CAL, suggesting the
importance of these two cytokines, especially IL-6, in the
early detection of CAL.
Nowadays the diagnosis of CAL still relies on clinical
presentation and imaging studies. Early clinical presentation
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Table 2: Quality assessment of the included studies by judging risk of bias and applicability using Quality Assessment of Diagnostic Accuracy
Studies-2 (QUADAS-2). +: low risk of bias; −: high risk of bias; ?: not specified.
Author Year
Risk of bias Applicability
Patient
Selection Index test
Reference
standard
Flow and
timing Patient selection Index test Reference standard
Bertram et al.
[23] 2003 − + − − + + −
Fouda et al.
[21] 2011 − + + − + + +
Herwig et al.
[24] 2002 − + + − + + +
Matthiessen
et al. [4, 19] 2007 − + + − + + +
Yamamoto et
al. [20] 2011 − + + − + + +
Ellebæk et al.
[25] 2014 − + ? − + + ?
Reisinger et
al. [26] 2014 − + + − + + +
Table 3: Definition of anastomotic leakage of included studies; CAL: colorectal anastomotic leakage.
Author Year Complication Definition
Bertram et al. [23] 2003 CAL
Patients were considered uneventful if recovery occurred
without signs of anastomotic leakage within 14 days after
operation
Fouda et al. [21] 2011 CAL
AL was defined clinically as gas, pus, or fecal discharge from the
drain, fecal discharge from the operative wound, pelvic abscess,
peritonitis, and rectovaginal fistula
Herwig et al. [24] 2002 CAL
Diagnosis of AL was confirmed by endoscopy, contrast enema,
abdominal CT scan, microbiologic examination, and finally
intraoperative findings during relaparotomy
Matthiessen et al. [4, 19] 2007 CAL
Peritonitis caused by leakage, pelvic abscess, discharge of feces
from the abdominal drain, or rectovaginal fistula, and leakage
from all staple lines
Yamamoto et al. [20] 2011 Peritonitis
The diagnosis of postoperative peritonitis was based on clinical
findings along with imaginary data and the colour of abdominal
exudates
Ellebæk et al. [25] 2014 CAL
Anastomotic leakage was defined as a demonstrated defect of
the intestinal wall at the anastomotic site leading to a
communication between the intra- and extraluminal
compartment’s
Reisinger et al. [26] 2014 CAL
Clinically relevant AL was defined as extra luminal presence of
contrast fluid on contrast CT scans and/or leakage when
relaparotomy was performed, requiring reintervention
is often heterogeneous and nonspecific, resulting in delay
of CAL diagnosis [9]. In many cases, CAL does not turn
clinically apparent until approximately the eighth postop-
erative day [30]; in some cases, CAL may even become
manifest until a median of the twelfth postoperative day
when many patients have already been discharged [8]. As
shown in our results, increased peritoneal levels of proin-
flammatory cytokines were observed on postoperative days
1–5, which is much earlier than the current median day of
CAL diagnosis [8]. IL-6 was especially higher in CAL patients
since the first postoperative day, indicating the possibility
of early detection of CAL by monitoring of intraperitoneal
cytokines. Such possibility has been reported by the previous
literature. The studies from Salgado et al. [31, 32] reported
that the increase of peritoneal cytokine levels is prior to the
clinical manifestations of anastomotic leakage or increase of
leukocytes in bariatric surgery. Similar investigations in the
field of colorectal surgery are also warranted.
We also attempted to explore whether the systemic
cytokine level could contribute to the early detection of
6 Gastroenterology Research and Practice
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(c)
Figure 2: Weighted means of peritoneal levels of TNF (a, ng/mL), IL-6 (b, ng/mL), and IL-1𝛽 (c, ng/mL) on each postoperative day (POD)
comparing colorectal anastomotic leakage (CAL) patients with non-CAL patients; TNF (a), IL-6 (b), and IL-1𝛽 (c).The 𝑃 values of differences
are illustrated when relevant.
CAL, since postoperative drainage is not often applied in
colonic surgeries nowadays [33–35]. Measurement of sys-
temic cytokinesmight be of great assistance to early detection
of CAL in patients without drainage if their early changes
can be determined as well. Unfortunately our data show
that higher levels of cytokines were only observed in the
peritoneal drainage but not in the blood sample. Despite the
lack of high level-of-evidence studies, our findings are in line
with the previous study fromWiik et al. who reported a more
extensive release of pro- and anti-inflammatory cytokines
into the peritoneal cavity after abdominal surgery compared
to the systemic response [12].This could be due to the fact that
lymphocytes and monocytes at the site of CAL secrete these
cytokines [36]. In addition, other studies have demonstrated a
poor diagnostic value of serumCRP or white blood cell count
in the early detection of CAL [37]. Accumulated evidence
verified that the systematic changes of CAL are rather latent
during the first postoperative days. Changes in systemic levels
of cytokines seem to only occur when a critical condition
emerges such as sepsis [38].
For the purpose of determining a reference level in
colorectal surgery, we used exact values rather than the
comparative risk ratios in statistical analysis, which was
previously reported by Cini et al. [39]. According to our
data, it seems that although many included studies reported
a significant risk of CAL with high cytokine levels, the
repeatability of the cytokine levels among different studies
still seems unsatisfactory. The variations in cytokine levels
may be caused by several reasons. As mentioned above, the
definition of CAL varies substantially among the included
studies (Table 3). The included articles used different defini-
tions of CAL, which correspond to different grades of CAL
according to the International StudyGroup on Rectal Cancer,
varying between subclinical CAL to the ones requiring
surgical intervention.This induced a mix of outcomes in this
meta-analysis.
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4
8
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3
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8
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Figure 4: Forest plot with 95% confidence interval (CI) of the mean difference of peritoneal levels of IL-6 (ng/mL) between colorectal
anastomotic leakage (CAL) patients and non-CAL patients per postoperative days (POD) 1 (a), 2 (b), 3 (c), 4 (d), and 5 (e).
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Due to the relatively low rate of infectious complications
after colorectal surgery, studies with high level-of-evidence
and a large amount of patients on such topic are difficult to
implement. It is understandable that, in this early stage, most
included studies yield very low level-of-evidence and high
risks of bias. (Nested) case-control studies are highly sensitive
to bias, especially to the selection bias, which may influence
reliability of the study results. Moreover, the included studies
have to deal with a limited sample size, which also decreases
the reliability. On the basis of these limitations the studies are
sensitive to the type II error (i.e., false negative). However this
type II error has limited influence to the positive results of
our analysis (for TNF and IL-6), supporting higher peritoneal
cytokine levels in CAL patients compared to uncomplicated
cases. Unfortunately, previous studies do not provide further
data regarding the sensitivity and specificity of the peritoneal
cytokine evaluation. Studies with high level-of-evidence and
large amount of inclusions to determine the role of peritoneal
cytokines in the early diagnosis of CAL are needed, which is
also one main focus of our on-going study.
5. Conclusions
In this meta-analysis, we investigated both peritoneal and
systemic cytokine levels after colorectal surgery. Our data
demonstrate that levels of the peritoneal proinflammatory
cytokines (i.e., TNF and IL-6) substantially increase in CAL
patients during the first postoperative days, suggesting their
potential diagnostic value, while the systemic cytokines have
limited additional value in this regard.High level-of-evidence
studies are warranted to determine the accuracy of peritoneal
cytokines in the early diagnosis of CAL.
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